Effect of Sublingual Formulation of Dexmedetomidine Hydrochloride (HCl) (BXCL501) – Outpatient Study
Condition(s):Alcohol Use Disorder (AUD); Post Traumatic Stress Disorder (PTSD)Last Updated:March 28, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Alcohol Use Disorder (AUD); Post Traumatic Stress Disorder (PTSD)Last Updated:March 28, 2024Not yet recruiting
Condition(s):Recalcitrant Lower Limb NonunionLast Updated:March 28, 2024Active, not recruiting
Condition(s):Severe Maternal MorbidityLast Updated:March 28, 2024Not yet recruiting
Condition(s):Rett Syndrome; Neurologic DisorderLast Updated:March 28, 2024Completed
Condition(s):Non-squamous Non-small Cell Lung CancerLast Updated:March 28, 2024Not yet recruiting
Condition(s):Head and Neck NeoplasmsLast Updated:March 28, 2024Recruiting
Condition(s):VapingLast Updated:March 28, 2024Not yet recruiting
Condition(s):DysphagiaLast Updated:March 28, 2024Completed
Condition(s):Idiopathic Pulmonary FibrosisLast Updated:March 28, 2024Not yet recruiting
Condition(s):Thoracic NeoplasmsLast Updated:March 28, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.